ARCHIVES

Bush Asks Hammer To Probe FDA Regulation Of Anticancer Drugs

This article is from The Cancer Letter archive.

Vol. 14 No. 25 | June 17, 1988

Download PDF Visit The Full Archive

Related Articles

In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials

March 2, 1984

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005

Zydelig Tablets Approved For Three Blood Cancers

July 25, 2014

NCI-Approved Clinical Trials

July 30, 2004

In Brief: Markup Of Cancer Act Renewal Bill Oct. 31; Garfinkel New ACS VP For Epidemiology

October 19, 1979

Northwestern’s Warren Kibbe Named Director of NCI CBIIT

June 26, 2013